Live Breaking News & Updates on Trabolsi Research Group
Stay updated with breaking news from Trabolsi research group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ The "UAE Human Insulin Market By Indication (Type I Diabetes, Type II Diabetes), By Route of Administration (Subcutaneous, Nasal, Intravenous,. ....
Tips to Care for Your Liver During COVID-19 by Colleen Fleiss on April 23, 2021 at 10:29 PM COVID-19 pandemic can be dangerous for people suffering from liver disease as they are at a higher risk of suffering from severe complications, say health experts. A case in point is the earlier SARS epidemic, during which liver damage was observed in more than half of the afflicted patients. Liver disease is a serious concern in India with more than 10 lakh cases being reported every year. Late diagnosis often leads to detection of the condition when it is at end-stage or liver cirrhosis has occurred, during which time it is difficult to treat and it could lead to death, says Rajiv Lochan, Lead Consultant HPB and Transplant Surgery, Aster RV Hospital. ....
It looks like this was the result of either: A mistyped address A broken link on our site A broken link on a search engine results page A broken link on someone else s page Some things to try: Use the navigation menu at the top Most Read ....
developed a new oral delivery system for insulin that could replace the traditional injection used by diabetes patients. improve the lives of those living with the disease. Researchers at the university’s Trabolsi Research Group developed layers of nanosheets with insulin loaded in between each layer. This technology responds quickly to an elevation in blood sugar, but would promptly shut off to prevent insulin overdose Farah Benyettou, Trabolsi Research Group In tests, patients sugar levels returned to normal within two hours of swallowing the nanoparticles, which are designed to withstand stomach acid and release their active ingredient in the intestine. ....
UAE: Varsity develops oral insulin delivery system Team KT/Abu Dhabi Filed on April 7, 2021 New York University Abu Dhabi research scientist Farah Benyettou and programme head of chemistry Ali Trabolsi. Supplied photo Compared to two FDA-approved oral systems for insulin delivery, NYUAD’s version is biocompatible A revolutionary technology developed by NYU Abu Dhabi (NYUAD) could replace painful insulin injections for diabetic patients. The Trabolsi Research Group at NYUAD have developed an insulin oral delivery system that could replace traditional subcutaneous injections. Led by NYUAD’s research scientist Farah Benyettou and programme head of chemistry Ali Trabolsi, the findings were published on Wednesday in Chemical Science. A US patent application is pending for this innovative technology. ....